Administration of nitric oxide synthase inhibitor 546C88 in septic shock.

Critical care medicine ·Vol. 32 ·No. 7 ·2004-07-00 ·Pages 1625; author reply 1625-6

Renes MH, van der Hoeven JG

Abstract

暂无摘要

MeSH Terms

Cardiac Output/drug effects Humans Nitric Oxide Synthase/antagonists & inhibitors Shock, Septic/drug therapy,mortality omega-N-Methylarginine/administration & dosage,adverse effects

Chemicals

omega-N-Methylarginine Nitric Oxide Synthase

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Renes Maurits H

van der Hoeven Johannes G

Article Info

Journal

Critical care medicine

Abbr.

Crit Care Med

ISSN

0090-3493

DOI

10.1097/01.ccm.0000128985.77253.c8

Published

2004-07-00

Pages

1625; author reply 1625-6

Language

English

Region

United States

NLM ID

0355501

Subset

Corrections

CommentOn

PMID: 14707556

External Links

PubMed source DOI: 10.1097/01.ccm.0000128985.77253.c8 View journal details

Analysis Services

Administration of nitric oxide synthase inhibitor 546C88 in septic shock.

Contact

WeChat Official Account